The Annual International Symposium on Myeloproliferative Neoplasms
* The program is subject to change without notice.
* Time listed in Japan Standard Time.
Time
Topic
Speaker
Moderator
09:00 – 09:05
Opening Remarks
Dr. Kazuya Shimoda
Basic Science
09:05 – 09:30
Elucidation of Molecular Pathophysiology of Myeloproliferative Neoplasms and Its Application to Therapeutic Decisions
Dr. Robert Kralovics
Dr. Jong-Jin Seo
09:30 – 09:55
Therapeutic Potential of an Antibody Targeting the Cleaved Form of Mutant Calreticulin in Myeloproliferative Neoplasms
Dr. Marito Araki
09:55 – 10:20
Fibrocytes in Myelofibrosis
Clinical Practice, Diagnostic and Treatment Strategy
10:20 – 10:45
Long-term Interferon Treatment for Polycythemia Vera
Dr. Richard Silver
Dr. Dong-Tsamn Lin
10:45 – 11:10
Objectives of Polycythemia Vera Treatment
Dr. Srdan Verstovsek
11:10 – 11:35
Halting Progression of Polycythemia Vera - Importance of Disease Burden Measurement
Dr. Ruben Mesa
11:35 – 12:00
Management of MPNs in Pregnancy
Dr. Yoko Edahiro
12:00 – 12:25
Chronic Myeloid Leukemia and Treatment in China
12:25 – 12:50
Diagnostic Challenges in Early MPN, MDS/MPN Overlaps, and New Molecular Data
Dr. Hans Michael Kvasnicka
12:50 – 13:15
Novel Mechanism-based Advances in the Treatment of MPNs
Dr. John Mascarenhas
13:15 – 13:50
Lunch Break
Interferon: History, Current Status and Future Prospects
13:50 – 14:15
Interferon History
Dr. Keita Kirito
Dr. Norio Komatsu
14:15 – 14:40
Ropeginterferon as an Early Treatment
Dr. Heinz Gisslinger
14:40 – 15:05
High Rate of Complete Molecular Response with Long-Term Use of Ropeginterferon Alfa-2b in PV
Dr. Jean-Jacques Kiladjian
15:05 – 15:30
Compassionate Use of Ropeginterferon Alfa-2b in Taiwan
Dr. Chih-Cheng Chen
15:30 – 15:55
Interferon Treatment for Chronic Myeloid Leukemia
Dr. Dong-Wook Kim
15:55 – 16:20
Interferon Treatment for Adult T-cell Leukemia/Lymphoma
Dr. Akifumi Takaori-Kondo
16:20 – 16:30
Break
Panel Discussion
16:30 – 16:55
Dr. Lee-Yung Shih
16:55 – 17:00
Closing Remarks